Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation Ajna Hamidovic Leading Article 22 April 2022 Pages: 411 - 417
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors Jeffrey S. WefelCharles J. RyanAlicia K. Morgans Review Article Open access 06 May 2022 Pages: 419 - 449
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders Richard C. J. BradlowMichael BerkRichard A. Kanaan Review Article Open access 22 March 2022 Pages: 451 - 482
Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies Katharine N. GurbaRida ChaudhrySimon Haroutounian Review Article 05 May 2022 Pages: 483 - 516
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain Luis Gutiérrez‐RojasSergio Sánchez-AlonsoPaola M. López Rengel Original Research Article Open access 23 April 2022 Pages: 517 - 527
Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden Essi HeinonenLisa ForsbergKarin Källén Original Research Article Open access 26 February 2022 Pages: 529 - 539
Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav®) in Sleep Disorders: A Profile of Its Use Young-A Heo Adis Drug Q&A Open access 31 March 2022 Pages: 541 - 549
Correction to: Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav®) in Sleep Disorders: A Profile of Its Use Young-A Heo Correction Open access 21 April 2022 Pages: 551 - 551
Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders Richard C. J. BradlowMichael BerkRichard A. Kanaan Correction Open access 28 April 2022 Pages: 553 - 553